Distribution of 42 Patients, Best Remission Status After First-Line Therapy, PFS, and OS According to MILAS
MILAS | Mean SUVmax | Patients (n) | Complete remission (n) | Complete remission + partial remission (n) | Median PFS (mo) | Median OS (mo) |
1 | 6.92 (SD, 2.92) | 12 (28.6%) | 10 (23.8%) | 12 (28.6%) | 59 | 59 |
2 | 9.07 (SD, 2.41) | 10 (23.8%) | 7 (16.7%) | 7 (16.7%) | 35 | NR |
3 | 14.79 (SD, 6.36) | 9 (21.4%) | 7 (16.7%) | 8 (19.0%) | NR | NR |
4 | 14.85 (SD, 3.73) | 5 (11.9%) | 5 (11.9%) | 5 (11.9%) | 14 | 29 |
5 | 14.38 (SD, 9.50) | 2 (4.8%) | 2 (4.8%) | 2 (4.8%) | 8 | 8 |
6 | 21.18 (SD, 2.21) | 3 (7.1%) | 1 (2.4%) | 3 (7.1%) | 3 | 9 |
7 | 0 | 0 | — | — | — | — |
8 | 0 | 0 | — | — | — | — |
9 | 18.89 (−) | 1 (2.4%) | 0 | 0 | 2 | 3 |
Summary | 42 (100%) | 32 (76.2%) | 37 (88.1%) | 29 | 59 |
NR = not reached.